Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Diane Warden |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment / Diane Warden en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)
[artículo]
Título : Early adverse events and attrition in selective serotonin reuptake inhibitor treatment : A suicide assessment methodology study report Tipo de documento: texto impreso Autores: Diane Warden, Autor ; Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor Fecha de publicación: 2022 Artículo en la página: pp. 259-266 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Deserción, Adherencia, Eventos adversos, Antidepresivo, Depresión Resumen: Adverse events during selective serotonin reuptake inhibitor (SSRI) treatment are frequent and may lead to premature treatment discontinuation. If attrition is associated with early worsening of adverse effects or the frequency, intensity, or burden of adverse effects, interventions to maximize retention could be focused on patients with these events. Link: ./index.php?lvl=notice_display&id=29450
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 259-266[artículo] Early adverse events and attrition in selective serotonin reuptake inhibitor treatment : A suicide assessment methodology study report [texto impreso] / Diane Warden, Autor ; Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor . - 2022 . - pp. 259-266.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 259-266
Palabras clave: Deserción, Adherencia, Eventos adversos, Antidepresivo, Depresión Resumen: Adverse events during selective serotonin reuptake inhibitor (SSRI) treatment are frequent and may lead to premature treatment discontinuation. If attrition is associated with early worsening of adverse effects or the frequency, intensity, or burden of adverse effects, interventions to maximize retention could be focused on patients with these events. Link: ./index.php?lvl=notice_display&id=29450